• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 9, 2019

View Archived Issues

Cytokinetics presents additional analysis data from FORTITUDE-ALS study

Read More

FDA clears IND application for a phase I study of MV-012-968 vaccine for RSV

Read More

Positive topline data reported from phase II pozelimab in patients with PNH

Read More

Sage Therapeutics reports topline data from pivotal phase III MOUNTAIN study

Read More

Epigenetic reactivation of ADGRB3 as novel therapeutic strategy in WNT-medulloblastoma

Read More

ONC-201 demonstrates clinical efficacy in patients with thalamic H3 K27M-mutant glioma

Read More

The brain - silicone's new frontier?

Read More

CC-90009 shows antileukemic activity in patients with relapsed/refractory acute myeloid leukemia

Read More

Phase I/II trial of MERT with a CXCR4 inhibitor improves local control in glioblastoma

Read More

Safety and efficacy of SST2 antagonist [177Lu]-satoreotide tetraxetan in advanced SST2+ NET

Read More

AAV2 capsid fitness landscape allows systematic optimization of natural capsids for gene therapy

Read More

ASH 2019: Gene editing can move cell therapy from biplane to Boeing era

Read More

Preliminary data presented for TN-383B in patients with relapsed or refractory multiple myeloma

Read More

HitGen presents new IL-17RA antagonists

Read More

Synlogic begins phase I study of SYNB-1891 in advanced/metastatic solid tumors and lymphoma

Read More

Lilly initiates phase I/II study of LY-3499446 in advanced solid tumors with KRAS G12C mutation

Read More

Abbisko Therapeutics identifies FGFR inhibitors

Read More

Sunshine Lake Pharma discloses mineralocorticoid receptor antagonists

Read More

Js Innomed Holdings synthesizes new ERK2 inhibitors

Read More

GlaxoSmithKline identifies new NFE2-related factor 2 activators

Read More

New phase II trial investigates OQL-011 for hand-foot skin reaction in cancer patients

Read More

Phase III BE SURE study of bimekizumab in plaque psoriasis meets coprimary endpoints

Read More

Phase III PRIMROSE 2 trial of linzagolix for heavy menstrual bleeding meets endpoints

Read More

Partial clinical hold for pediatric patients in Ipsen's FOP and MO studies of palovarotene

Read More

Phase III study of nadofaragene firadenovec in bladder cancer meets primary endpoint

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 10, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 10, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 10, 2025
  • Red blood cells in an artery with cholesterol

    In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol

    BioWorld
    In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...
  • Cancer cell in the cross-hairs

    Pan-cancer proteome atlas reveals new biomarkers and targets

    BioWorld Science
    An international group of scientists has completed the first draft of The Pan-Cancer Proteome Atlas (TPCPA). The project is based on mass spectrometry of 22...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe